Learn About Hemoglobin C Disease

What is the definition of Hemoglobin C Disease?

Hemoglobin C disease is a blood disorder passed down through families. It leads to a type of anemia, which occurs when red blood cells break down earlier than normal.

What are the alternative names for Hemoglobin C Disease?

Clinical hemoglobin C

What are the causes of Hemoglobin C Disease?

Hemoglobin C is an abnormal type of hemoglobin, the protein in red blood cells that carries oxygen. It is a type of hemoglobinopathy. The disease is caused by a problem with a gene called beta globin.

The disease most often occurs in African Americans. You are more likely to have hemoglobin C disease if someone in your family has had it.

What are the symptoms of Hemoglobin C Disease?

Most people do not have symptoms. In some cases, jaundice may occur. Some people may develop gallstones that need to be treated.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hemoglobin C Disease?

In most cases, no treatment is needed. Folic acid supplements may help your body produce normal red blood cells and improve the symptoms of the anemia.

Who are the top Hemoglobin C Disease Local Doctors?
Experienced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology
Experienced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology

Barbara Ann Karmanos Cancer Institute

4100 John R St, 
Detroit, MI 
 (210.3 mi)
Languages Spoken:
English, Arabic
Accepting New Patients
Offers Telehealth

Tarik Hadid is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Hadid and is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Thrombocytopenia, Lung Cancer, Appendix Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Hadid is currently accepting new patients.

Experienced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology
Experienced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology

Osf Multi-Specialty Group

2525 5th Ave S, 
Escanaba, MI 
 (98.1 mi)
Languages Spoken:
English
Accepting New Patients

Matthew Ryan is a Hematologist Oncology specialist and a Hematologist in Escanaba, Michigan. Dr. Ryan and is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Lung Adenocarcinoma, Chronic Inflammatory Demyelinating Polyneuropathy, Acquired Hemophilia, Bone Marrow Aspiration, and Gastrostomy. Dr. Ryan is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology
Advanced in Hemoglobin C Disease
Hematology Oncology | Hematology | Oncology

Mclaren Oakland

5680 Bow Pointe Dr, Suite 202, 
Clarkston, MI 
 (179.7 mi)
Languages Spoken:
English, Greek
Accepting New Patients

Seraphim Pallas is a Hematologist Oncology specialist and a Hematologist in Clarkston, Michigan. Dr. Pallas and is rated as an Advanced provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Congenital Antithrombin 3 Deficiency, Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, Protein S Deficiency, and Bone Marrow Aspiration. Dr. Pallas is currently accepting new patients.

What is the outlook (prognosis) for Hemoglobin C Disease?

People with hemoglobin C disease can expect to lead a normal life.

What are the possible complications of Hemoglobin C Disease?

Complications may include:

  • Anemia
  • Gallbladder disease
  • Enlargement of the spleen
When should I contact a medical professional for Hemoglobin C Disease?

Contact your health care provider if you have symptoms of hemoglobin C disease.

How do I prevent Hemoglobin C Disease?

You may want to seek genetic counseling if you are at high risk for the condition and are considering having a baby.

What are the latest Hemoglobin C Disease Clinical Trials?
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Summary: The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: March 31, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Howard J. Sickle cell disease and other hemoglobinopathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 149.

Smith-Whitley K, Kwiatkowski JL. Hemoglobinopathies. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 511.

So JCC, Ma ESK. Hemoglobin and hemoglobinopathies. In: Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. St Louis, MO: Elsevier; 2023:chap 77.

Wilson CS, Vergara-Lluri ME, Brynes RK. Evaluation of anemia, leukopenia, and thrombocytopenia. In: Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:chap 11.